Dr Irma Pujol Autonell
I started my research career in 2007 as an undergraduate student at the Anthony Nolan Research Institute in London. After obtaining my bachelor's degree in Biotechnology at the Autonomous University of Barcelona in Spain, I joined the Immunology Unit at the Germans Trias i Pujol Research Institute in Badalona. I was focused on developing and characterizing new immunotherapy based on apoptosis to restore tolerance in type 1 diabetes. I obtained my PhD in July 2014 and I continued working on the development of synthetic immunotherapy for type 1 diabetes in the same group. I joined Professor Mark Peakman’s group at the King’s College London in September 2016 as a post-doc researcher with a Marie Curie European Individual Fellowship. My goals are to understand the immunological mechanisms of destruction in the context of type 1 diabetes to apply that knowledge into antigen-specific immunotherapies to treat the disease.